Biohaven Launch on Track in Spite of Everything
The FDA approved Biohaven Pharmaceuticals’ migraine therapy, Nurtec, last month, just before the COVID-19 pandemic sent people the world over into lockdown.
The FDA approved Biohaven Pharmaceuticals’ migraine therapy, Nurtec, last month, just before the COVID-19 pandemic sent people the world over into lockdown.